Page 2607
Apr 29, 2023
New method improves accuracy of DNA sequencing 1,000-fold to detect rare genetic mutations
Posted by Genevieve Klien in categories: biotech/medical, genetics
A team of researchers at the Broad Institute of MIT and Harvard has developed a new approach to next-generation sequencing that detects genetic mutations within single molecules of DNA.
The method, called Concatenating Original Duplex for Error Correction (CODEC), makes next-generation sequencing about 1,000 times more accurate and opens up the possibility of a range of applications including detecting tiny numbers of cancer mutations in blood samples, monitoring cancer during and after treatment, and identifying mutations underlying rare diseases, all at relatively low cost. The study appears today in Nature Genetics.
“The beauty of this approach is that it’s not an overhaul of how sequencing is done,” said Viktor Adalsteinsson, senior author on the study and director of the Gerstner Center for Cancer Diagnostics and leader of the Blood Biopsy Team at the Broad. “It’s not something that requires new instrumentation or capital investment —it’s a simple set of steps added into existing sample preparation workflows to improve the accuracy of DNA sequencing.”
Apr 29, 2023
Seattle startup gets FDA clearance for new surgical imaging tool
Posted by Genevieve Klien in category: biotech/medical
A Seattle medical tech company’s revolutionary surgical imaging instrument has become the first light-enabled navigation tool for spine surgery to receive Food and Drug Administration clearance.
Why it matters: Officials with Proprio believe the tool, which allows surgeons to essentially “see” the spine being operated on in real time, could dramatically improve clinical outcomes.
Driving the news: This month, the Paradigm device received the FDA 510(k) clearance that’s required for new medical implements before they are taken to market, Proprio said in an emailed announcement.
Apr 29, 2023
Elderly people can improve episodic memory via neurostimulation of the cerebellum, shows study
Posted by Genevieve Klien in categories: biotech/medical, life extension, neuroscience
A recent study demonstrated that non-invasive stimulation of the right cerebellum led to improvements in episodic memory performance in healthy elderly individuals, at the end of a 12-day neurostimulation program, and also at the point of a 4-month follow-up.
The steady increase in average life expectancy poses significant challenges to individuals, families, and societies across multiple dimensions. Estimating that by 2050 one in every six individuals will be over the age of 65, the study of aging and its association with cognitive decline, neurodegenerative diseases and overall frailty is becoming increasingly important.
Therefore, it has been an important goals of neurosciences research to understand the relationship between the aging brain and episodic memory deficits and to develop interventions to mitigate the age-related decline in our ability to remember personal past events (episodic memory).
Apr 29, 2023
Augmenting and accelerating humans
Posted by Genevieve Klien in categories: cybercrime/malcode, robotics/AI
Join top executives in San Francisco on July 11–12, to hear how leaders are integrating and optimizing AI investments for success. Learn More
~“May you live in interesting times”~
Having the blessing and the curse of working in the field of cybersecurity, I often get asked about my thoughts on how that intersects with another popular topic — artificial intelligence (AI). Given the latest headline-grabbing developments in generative AI tools, such as OpenAI’s ChatGPT, Microsoft’s Sydney, and image generation tools like Dall-E and Midjourney, it is no surprise that AI has catapulted into the public’s awareness.
Apr 29, 2023
Bold new therapy delivery method shows initial promise as treatment for Duchenne muscular dystrophy
Posted by Genevieve Klien in categories: bioengineering, biotech/medical
Doug Millay, Ph.D., a scientist with the Division of Molecular Cardiovascular Biology at Cincinnati Children’s has dedicated his career to revealing the most fundamental mechanisms of skeletal muscle development. He has been a leader in characterizing how two “fusogens” called Myomaker and Myomerger mediate the entry of stem cells into mature muscle cells to build the tissue that humans depend upon for movement, breathing, and survival.
Now, some of the basic discoveries made by Millay and colleagues are translating into a potential treatment for people living with Duchenne muscular dystrophy (DMD). Their latest research, published April 12, 2023, in the journal Cell, reveals that in mice, modified viruses, engineered with Myomaker and Myomerger, result in specific fusion with muscle cells. These viruses can therefore be used as a vector to deliver a vital gene needed for muscle function that is mutated in people with DMD.
A key unknown prior to this work was whether proteins like Myomaker and Myomerger, which mainly function on cells, could even work on viruses. First author Sajedah Hindi, Ph.D., also with the Division of Molecular Cardiovascular Biology at Cincinnati Children’s and a leading member of the research team, took on the challenge to test this idea.
Apr 29, 2023
Time Travel and it’s Possibility
Posted by Dan Breeden in categories: physics, robotics/AI, time travel
Created using Paragraph ai.
Time travel has long been a popular theme in movies, but scientists believe that the concept of time teleportation is unlikely in reality. However, they do not dismiss the possibility of time travel altogether. The laws of physics suggest that time travel may be possible, but the details are complex.
Physicists explain that traveling to the near future is relatively simple, as we are all doing it right now at a rate of one second per second. Additionally, Einstein’s special theory of relativity states that the speed at which we move affects the flow of time. In other words, the faster we travel, the slower time passes. Furthermore, Einstein’s general theory of relativity suggests that gravity also impacts the flow of time. The stronger the nearby gravity, the slower time goes.
Apr 29, 2023
Timber! The World’s First Wooden Transistor
Posted by Dan Breeden in categories: chemistry, computing, engineering
“It was very curiosity-driven,” says Isak Engquist, a professor at Linköping University who led the effort. “We thought: ‘Can we do it? Let’s do it, let’s put it out there to the scientific community and hope that someone else has something where they see these could actually be of use in reality.’”
“I have colleagues who are at the forefront in a field we call electronic plants. … We have worked with dead woods for this project, but the next step might be to integrate it also into living plants.” —Isak Engquist, Linköping University.
Even though the wooden transistor still awaits its killer app, the idea to build wood-based electronics is not as crazy as it sounds. A recent review of wood-based materials reads, “Around 300 million years of tree evolution has yielded over 60,000 woody species, each of which is an engineering masterpiece of nature.” Wood has great structural stability while being highly porous and efficiently transporting water and nutrients. The researchers leveraged these properties to create conducting channels inside the wood’s pores and electrochemically modulate their conductivity with the help of a penetrating electrolyte.
Apr 29, 2023
Microsoft Edge users who use Google Bard get a bonus annoying Bing ad
Posted by Gemechu Taye in category: robotics/AI
A developer release of Microsoft’s Edge browser has a new address bar advertisement for the company’s Bing AI — but it only appears when the user goes to its main competitor’s site at bard.google.com.
Microsoft’s Edge can be a great Chromium browser alternative to Google’s Chrome, but the former is displaying some annoying new rivalry antics: advertising Microsoft’s Bing AI chatbot while you’re trying out Google’s Bard AI. As pointed out by developer and Twitter user Vitor de Lucca, a new developer version of Edge will now display a new Bing ad next to the Google Bard URL.
When pointing Edge to bard.google.
Continue reading “Microsoft Edge users who use Google Bard get a bonus annoying Bing ad” »